Glucagonoma: Difference between revisions
CSV import Tag: Reverted |
No edit summary Tag: Manual revert |
||
| Line 30: | Line 30: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
Revision as of 17:13, 22 March 2025
Glucagonoma is a rare tumor of the pancreatic alpha cells that results in an overproduction of the hormone glucagon. This condition is often associated with a syndrome of symptoms, known as Glucagonoma syndrome.
Symptoms
The symptoms of Glucagonoma can vary widely and may include:
- Diabetes mellitus: High levels of glucagon can interfere with the body's ability to regulate blood sugar, leading to diabetes.
- Necrolytic migratory erythema (NME): This is a skin condition characterized by red, blistering rashes that spread across the skin.
- Weight loss: Unintentional weight loss is a common symptom of Glucagonoma.
- Anemia: This is a condition characterized by a lack of healthy red blood cells in the body.
- Deep vein thrombosis (DVT): This is a blood clot that forms in a vein deep in the body, often in the leg.
Diagnosis
Diagnosis of Glucagonoma often involves a combination of blood tests, imaging studies, and sometimes a biopsy of the tumor. Blood tests can measure the level of glucagon in the body, while imaging studies such as CT scans or MRIs can help identify the location and size of the tumor.
Treatment
Treatment for Glucagonoma typically involves surgery to remove the tumor. In some cases, additional treatments such as chemotherapy or radiation therapy may be used. Medications may also be prescribed to help manage symptoms and control blood sugar levels.
Prognosis
The prognosis for Glucagonoma can vary depending on the size and location of the tumor, as well as the individual's overall health. Early detection and treatment can improve the prognosis.


